ABPI votes for new code of practice that will restrict branded giveaways in the UK
This article was originally published in Scrip
Executive Summary
Members of the Association of the British Pharmaceutical Industry (ABPI) last week voted for a new code of practice that aims to improve transparency in its dealings with healthcare professionals and make it a more credible partner in the healthcare system. One measure intended to achieve this will do away with branded giveaways for healthcare professionals, despite being criticised by smaller firms earlier this year.
You may also be interested in...
Germany Confirms No Reimbursement Status For ‘Lifestyle’ Drug Wegovy
In Germany Novo Nordisk’s obesity drug Wegovy will remain excluded from reimbursement for obesity, unlike Rhythm’s Imcivree.
New HTA Evidence Guidelines In EU Could Spell Trouble For Advanced Therapy Companies
New guidelines that cast doubt over use of single-arm and non-randomized studies are “discouraging” for rare disease patients and the advanced therapy sector, says ARM, the Alliance for Regenerative Medicines.
Germany Courts Clinical Trials With Regulator Reshuffle & New Federal Ethics Committee
Plans to rejig two regulators’ roles and streamline the ethics committee system have drawn some criticism.